Intercellular Adhesion Molecule-1 K469E and Angiotensinogen T207M Polymorphisms in Coronary Slow Flow
dc.contributor.author | Gazi, Emine | |
dc.contributor.author | Barutcu, Ahmet | |
dc.contributor.author | Altun, Burak | |
dc.contributor.author | Temiz, Ahmet | |
dc.contributor.author | Bekler, Adem | |
dc.contributor.author | Urfali, Mine | |
dc.contributor.author | Sılan, Fatma | |
dc.date.accessioned | 2025-01-27T20:58:08Z | |
dc.date.available | 2025-01-27T20:58:08Z | |
dc.date.issued | 2014 | |
dc.department | Çanakkale Onsekiz Mart Üniversitesi | |
dc.description.abstract | Objective: To investigate intercellular adhesion molecule-1 (ICAM1) and angiotensinogen (AGT) gene polymorphisms, as related to atherosclerosis and endothelial dysfunction, in coronary slow flow (CSF). Subjects and Methods: The participants in this study were 48 patients with CSF and 67 patients with normal coronary flow as controls. The K469E polymorphism of ICAM1 (rs5498) and the T207M polymorphism of AGT (rs4762) were determined using the polymerase chain reaction amplification method. Results: Baseline demographic parameters were similar in both groups. The mean thrombolysis in myocardial infarction frame count was significantly higher in patients with CSF (23.8 +/- 5.1) compared to the controls (13.3 +/- 2.6, p < 0.001). A significant association was found between the ICAM1 K allele and CSF (OR: 1.96, 95% CI: 1.15-3.35, p = 0.013). There was no difference in the frequency of AGT T207M genotypes in the patients with CSF and the control subjects. Conclusion: This study showed that K469E polymorphisms of ICAM1 that play a role in atherosclerotic pathogenesis are related to CSF. (C) 2014 S. Karger AG, Basel | |
dc.description.sponsorship | Canakkale Onsekiz Mart University [TSA-2013-99] | |
dc.description.sponsorship | Our study on genetic polymorphisms in CSF was supported by the Research Fund of the Canakkale Onsekiz Mart University (project No. TSA-2013-99). | |
dc.identifier.doi | 10.1159/000363451 | |
dc.identifier.endpage | 350 | |
dc.identifier.issn | 1011-7571 | |
dc.identifier.issn | 1423-0151 | |
dc.identifier.issue | 4 | |
dc.identifier.pmid | 24942509 | |
dc.identifier.scopus | 2-s2.0-84905050194 | |
dc.identifier.scopusquality | Q1 | |
dc.identifier.startpage | 346 | |
dc.identifier.uri | https://doi.org/10.1159/000363451 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12428/26619 | |
dc.identifier.volume | 23 | |
dc.identifier.wos | WOS:000339731600010 | |
dc.identifier.wosquality | Q2 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | |
dc.publisher | Karger | |
dc.relation.ispartof | Medical Principles and Practice | |
dc.relation.publicationcategory | info:eu-repo/semantics/openAccess | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.snmz | KA_WoS_20250125 | |
dc.subject | ICAM1 polymorphism | |
dc.subject | Angiotensinogen polymorphism | |
dc.subject | Coronary slow flow | |
dc.subject | Atherosclerosis | |
dc.title | Intercellular Adhesion Molecule-1 K469E and Angiotensinogen T207M Polymorphisms in Coronary Slow Flow | |
dc.type | Article |